Precision's Jena to Participate in Upcoming AEI Forum
Precision's Principal Consultant Anupam Jena has been invited by the AEI to participate in a upcoming forum: "Rethinking the storyline for defensive medicine and medical liability: Causes, effects, and remedies." The forum will be held on December 2nd, 2015 from 3:30-5:00pm ET at the AEI in Was ...
Precision's Karen Becker Quoted in Roll Call
Precision for Medicine’s Karen Becker has been quoted in the latest edition of Roll Call, as Congress considers regulation of Lab-Developed Tests.
Here is the complete article:
November 20, 2015
Congress Considers Regulation of Lab-Developed Tests
By Andrew Siddons
As the Food ...
Precision for Value Acquires Redwood Outcomes
Extends Leadership and Global Reach in Health Economics and Outcomes Research
Gladstone, N.J. and Vancouver, B.C., November 4, 2015 – Precision for Value (Precision) today announced that it has acquired Redwood Outcomes, a leading international health economics and outcomes research (HEOR) ...
Chandra and Goldman in Harvard Business Review
Precision's Chief Scientific Officer Amitabh Chandra and PHE founding partner Dana Goldman address health care's Short-Termism problem in their latest article for the Harvard Business Review.
To view the complete article, please click here.
Precision Digital Trends Survey: What Payers Want From Pharma Can Vary
New York, August 26, 2015 – Precision Advisors (www.precisionadvisors.com), a Precision for Value company, today announced additional findings from its 2015 Digital Trends Study of managed care executives on the types of information Managed Care Organizations (MCOs) requested and received fro ...
Precision's MacEwan Participates in NEHI "On Call" Series
The Network for Excellence in Health Innovation (NEHI) held a special forum on August 19th, focusing on better use of medicines in diabetes, featuring the recent study and ADA presentation by Precision's Joanna MacEwan.
Dr. MacEwan discussed her recent work and fielded questions from the NEHI ...
Philipson in Forbes: "Dying to Live"
Tomas Philipson's latest Forbes.com Op-Ed examines end of life care, and why health care is so valuable in the face of death.
To read the complete article, please click here.
Precision in Bioprocess Online
Precision’s Deb Phippard, PhD, and Jared Kohler, PhD, address the potential of Big Data, analytics, and technology to increase efficiency and decrease costs in the drug development process in a guest column for Bioprocess Online. Read the full article here.
Precision's Ton Teaches NIH Course
Precision Associate Director and Senior Research Epidemiologist Thanh Ton has been selected by the National Institutes of Health to teach data management and analysis at the NIH/Fogarty Global Health Program for Scholars and Fellows, to be held July 10-15th in Bethesda, MD. This is Dr. Ton's thi ...
PHE's Goldman Elected to ISPOR Board of Directors
Precision is proud to announce that founding partner Dana Goldman has been elected to ISPOR's Board of Directors, effective July 1st, 2015. The Board of Directors are elected by ISPOR members – over 9,500 global members were given the opportunity to vote for nominated candidates.
The Intern ...